Yuvidoc SP Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Serratiopeptidase 10 mg. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyresis through central inhibition of prostaglandin synthesis, complementing Diclofenac’s peripheral action. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and tissue inflammation. This combination is indicated for the management of acute and chronic inflammatory conditions such as musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries. Yuvidoc SP Tablet offers rapid and sustained relief from pain and inflammation while improving functional mobility. It should be used under medical supervision, particularly in patients with gastrointestinal, hepatic, or renal impairment, and is contraindicated in individuals with hypersensitivity to any component or a history of NSAID-induced asthma or allergic reactions. Caution is advised during concomitant use with anticoagulants or other NSAIDs. The dosage regimen should be tailored to the patient’s clinical condition to optimize therapeutic outcomes and minimize adverse effects.